Overview

  • Product name

    Lanreotide, Somatostatin receptor analog
  • Description

    Somatostatin receptor analog
  • Biological description

    Somatostatin receptor analog (IC50 values are >1000 (sst1), 1.1 (sst2), 15 (sst3), 22 (sst4) and 21 nM (sst5)). Reduces hormone production in neuroendocrine tumors. Active in vivo.
  • Purity

    > 95%
  • CAS Number

    108736-35-2
  • Chemical structure

    Chemical Structure

Properties

References

This product has been referenced in:

  • Ning S  et al. Lanreotide promotes apoptosis and is not radioprotective in GH3 cells. Endocr Relat Cancer 16:1045-55 (2009). Read more (PubMed: 19528243) »
  • Smith-Jones PM  et al. DOTA-lanreotide: a novel somatostatin analog for tumor diagnosis and therapy. Endocrinology 140:5136-48 (1999). Read more (PubMed: 10537142) »
  • Häyry P  et al. Somatostatin analog lanreotide inhibits myocyte replication and several growth factors in allograft arteriosclerosis. FASEB J 7:1055-60 (1993). Read more (PubMed: 8370476) »

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab141209.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES, NOT FOR USE IN HUMANS"
For licensing inquiries, please contact partnerships@abcam.com

Sign up